#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

sepse

New Hematological Biomarker for Early Diagnosis of Sepsis

13. 9. 2021 Source: Because

Sepsis is one of the leading causes of mortality and healthcare expenditure worldwide. Early diagnosis and treatment of septic conditions improve patient prognosis. However, the initial symptoms of sepsis can be difficult to distinguish from other acute conditions due to similar symptomatology. The results of the study presented below indicate that a new hematological biomarker has the potential to facilitate the early diagnosis of sepsis.

Kašel

Interstitial Lung Processes and Their Fibrotic Progression

Interstitial lung processes (ILPs) include more than 200 clinical units that share diffuse…
10. 9. 2021 Source: Progressive Interstitial Pulmonary Processes
klinicka studie

Evaluation of Continuity of Care in Patients with mCRC –⁠ Baseline Characteristics of Participants in the PROMETCO Study

During this year's World Congress of the European Society for Medical Oncology (ESMO) on gastrointestinal...
9. 9. 2021 Source: Treatment of Gastrointestinal Carcinomas
kongres doktorov

Trifluridine/tipiracil in Real Clinical Practice –⁠ Current Data from Spain

Trifluridine/tipiracil is indicated for the treatment of patients with refractory metastatic colorectal...
9. 9. 2021 Source: Treatment of Gastrointestinal Carcinomas
CLL prezentace Abbvie ilustrační

Evaluation of Treatment Response in CLL

The size of lymph nodes, liver, spleen, blood cell counts, systemic symptoms... Changes in these indicators...
9. 9. 2021 Source: Chronic Lymphocytic Leukemia
plíce

Idiopathic Pulmonary Fibrosis: Can This Disease Be Named More Precisely?

Much about idiopathic pulmonary fibrosis (IPF) is still unknown. Some experts would like to…
9. 9. 2021 Source: Progressive Interstitial Pulmonary Processes
statistiky business grafy kancelář práce studie

Brigatinib in the Therapy of ALK-Positive NSCLC in Patients Refractory to Crizotinib Therapy –⁠ Results of the Final Analysis of Clinical Studies

Previously published results of clinical studies have shown that in patients refractory to…
9. 9. 2021 Source: Non-Small Cell Lung Cancer
PL_terapie_analyza_telo_technologie

Brigatinib in the Therapy of ALK-Positive NSCLC –⁠ First Results of the J-ALTA Study

Brigatinib is an anaplastic lymphoma kinase (ALK) inhibitor with broad and potent activity against…
9. 9. 2021 Source: Non-Small Cell Lung Cancer
srdce cevy cholesterol krev ateroskleroza

Ivabradine and/or Sacubitril/Valsartan in the Treatment of Heart Failure with Reduced Ejection Fraction

Ivabradine and sacubitril/valsartan are used in the second line of therapy for heart failure with…
7. 9. 2021 Source: Chronic Heart Failure and Lipidology
rano dělá den žena úsměv pohoda nálada

Variability of COPD Symptoms During the Day and Impact on Patients' Morning Routine –⁠ Survey Results

Chronic obstructive pulmonary disease (COPD) is viewed, unlike bronchial asthma, as a condition…
7. 9. 2021 Source: COPD
1 102 103 104 105 106 168
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#